Abstract
This article serves as a practical update on the performance and clinical application of fractional flow reserve (FFR) in the evaluation of intermediate coronary stenoses. We review several methods for the induction of hyperemia, viability after myocardial infarction, the impact of diabetes, and the use of FFR in myocardial bridging. New data on the correlation of FFR with noninvasive imaging in multivessel disease are presented. Additionally, we touch on the growing body of FFR-guided revascularization trials.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
